+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type, Testing Type, Technology, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010884
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biopharmaceuticals Manufacturing Consumables Testing Market grew from USD 621.39 million in 2024 to USD 696.93 million in 2025. It is expected to continue growing at a CAGR of 11.82%, reaching USD 1.21 billion by 2030.

Unveiling the Foundations of Biopharmaceutical Testing Consumables

The landscape of biopharmaceutical manufacturing relies fundamentally on the precision and reliability of consumables testing. From the earliest purification steps to final release assays, each consumable-whether chromatography media, filtration membranes, or single-use assemblies-serves as a critical barrier against contamination and a guarantor of product integrity. As development timelines accelerate and regulatory scrutiny intensifies, manufacturers must align their operational frameworks with the highest standards of quality assurance and supply chain resilience.

In recent years, the interplay between innovation and production scale has heightened demand for advanced testing consumables that can accommodate both flexibility and reproducibility. Single-use technologies have diminished cross-batch risks, while chromatography resins and depth filters have evolved to deliver enhanced throughput and selectivity. Concurrently, regulatory agencies are reinforcing requirements for endotoxin, sterility, and bioburden assessments, placing further emphasis on validated testing platforms and traceable supply chains.

Against this backdrop, stakeholders across academic research, contract development organizations, and large-scale biopharmaceutical manufacturers are seeking new methods to streamline testing workflows without compromising data integrity. This report offers a foundational overview of current materials, regulatory drivers, and emerging technologies, equipping decision-makers with the contextual understanding needed to navigate this complex and rapidly evolving domain.

Disruptive Trends Accelerating Consumables Testing Evolution

Recent years have witnessed transformative shifts redefining the throughput and precision of consumables testing within biopharmaceutical manufacturing. The rapid adoption of single-use bags and assemblies has transformed upstream and downstream workflows by reducing turnaround times for cleaning validation and minimizing cross-contamination. At the same time, chromatography technologies have converged with real-time analytical platforms, enabling process analytical technology (PAT) applications that deliver on-the-fly quality control and data-driven process adjustments.

Moreover, the rise of advanced molecular diagnostics-such as real-time polymerase chain reaction (PCR) and flow cytometry-has accelerated the detection of microbial contaminants and cell culture anomalies. These tools, when integrated alongside traditional cartridge and membrane filters, furnish robust multi-layered defense mechanisms against product spoilage. In parallel, sustainability considerations and single-use reprocessing initiatives have prompted suppliers to innovate materials that reduce environmental footprints without sacrificing performance.

Consequently, manufacturers are realigning their supply chains to prioritize vendors capable of delivering validated consumables that meet rigorous global standards. This convergence of digital analytics, material science, and regulatory convergence is reshaping how quality, cost, and speed coalesce in the quest to meet increasing production demands.

Navigating Cost Pressures from 2025 US Tariffs

In 2025, newly imposed United States tariffs have introduced a series of downstream effects on sourcing and cost structures for critical testing consumables. Manufacturers reliant on imported chromatography resins and filtration components now face higher landed costs that directly influence production margins. As a result, procurement teams are reevaluating supplier portfolios and exploring opportunities for nearshoring or regional sourcing partnerships to mitigate these additional expenses.

Additionally, the tariff environment has created a ripple effect across contract manufacturing organizations and contract research organizations, where tight project budgets and fixed-price agreements intensify revenue pressure. Some organizations have responded by increasing buffer inventories or securing long-term supply contracts at pre-tariff pricing, thereby safeguarding against future volatility. However, such strategies have also introduced inventory carrying costs and cash flow constraints that demand careful financial planning.

In light of these challenges, stakeholders are accelerating investments in process intensification and in-house development of testing crucial materials. By integrating modular manufacturing platforms and fostering strategic alliances with local suppliers, manufacturers can partially offset tariff-driven cost inflation while preserving the agility required for rapid method transfers and scale-ups.

Deep-Dive into Segmentation Driving Testing Choices

Insights emerging from the analysis of product types reveal that chromatography media remains a cornerstone for purification workflows. Protein A resins continue to dominate antibody capture processes, whereas ion exchange and size exclusion media have seen refinements that enhance selectivity and reduce cycle times. In filtration consumables, membrane filters exhibit superior sterilizing performance, yet depth filters gain traction for high-cell-density systems thanks to their extended throughput capacities. Single-use bags and assemblies, from bioreactor bags to storage vessels, are increasingly engineered for integrated sampling and sensor compatibility, improving real-time monitoring capabilities.

Testing type segmentation highlights that bioburden and endotoxin assays maintain their role as primary quality control measures, even as pH and sterility testing evolve through more automated platforms. Within sterility testing, membrane filtration tests are favored for high-volume batches, while direct inoculation methods remain essential for rapid turnaround in low-volume applications. These distinctions guide laboratories toward balanced portfolios of rapid and traditional assays to accommodate varied production scales.

Technological segmentation underscores how ELISA-based approaches, particularly sandwich ELISA formats, deliver high specificity for biomarker quantification, whereas competitive ELISA assays offer versatility for small-molecule detection. Real-time PCR has emerged as the gold standard for microbial monitoring, supported by mass spectrometry’s capabilities in host cell protein analytics and flow cytometry’s precision in cellular viability assessments.

Application-focused insights illustrate that cell culture monitoring benefits significantly from integrated inline sensors and automated sampling assemblies. In the domain of protein purification, affinity chromatography continues to set benchmarks for purity, with ion exchange and size exclusion chromatography supplementing polishing operations. For viral clearance studies, specialized filtration consumables and tailored sterility assays play indispensable roles in ensuring patient safety.

End-user segmentation shows that academic and research institutes demand flexible, cost-effective testing kits for exploratory work, while biopharmaceutical companies-spanning biosimilar manufacturers to large and mid-size pharma-prioritize validated, scalable consumables. Contract manufacturing and research organizations seek standardized product suites that streamline method transfers and compliance across multiple client engagements.

Regional Dynamics Shaping Testing Infrastructure

Regional dynamics exhibit distinct patterns of innovation, regulation, and supply chain structure. In the Americas, a strong emphasis on local manufacturing and regulatory convergence through harmonized guidelines has driven rapid adoption of single-use systems and digital testing platforms. Proximity to major biomanufacturing hubs has enabled faster supply chain responsiveness, yet it has also led to heightened competition for premium consumables.

The Europe, Middle East & Africa region reflects a tapestry of regulatory frameworks and sustainability mandates. Manufacturers in Western Europe invest heavily in closed-system filtration solutions and advanced PAT-enabled consumables to comply with stringent environmental and quality directives. Meanwhile, emerging markets within the same region are rapidly scaling capacity and leaning on technology transfers to establish robust local testing infrastructures.

Asia-Pacific continues to expand its footprint in both development and production. Countries with established pharmaceutical sectors deploy real-time PCR and ELISA platforms extensively, supported by investments in mass spectrometry for complex biosimilar analytics. In parallel, regional governments are incentivizing domestic production of single-use assemblies and chromatography media to reduce reliance on imports and fortify supply chain resilience.

Strategic Moves by Leading Consumables Suppliers

Key industry participants are driving innovation through strategic investments, partnerships, and targeted product expansions. Major players with comprehensive chromatography and filtration portfolios are enhancing their offerings by integrating sensor-enabled single-use assemblies and automated sampling platforms. Their emphasis on digital compatibility aligns with broader moves toward facility-wide data management systems and real-time monitoring dashboards.

At the same time, specialized technology firms are advancing niche solutions: providers of ELISA and real-time PCR assays are developing multiplex capabilities to streamline consecutive testing of endotoxin, bioburden, and pH parameters. Companies focused on mass spectrometry are broadening their reagent and software ecosystems to support deeper host cell protein and metabolite profiling. These developments enable contract organizations and research institutes to accelerate method qualification and regulatory submissions without sacrificing analytic depth.

Competitive dynamics also revolve around service offerings. Several leading suppliers now bundle consumables with on-site validation support, training modules, and digital assay management platforms to bolster customer retention and shorten adoption curves. Through collaborative innovation agreements with academic centers and pilot plant facilities, these companies are co-developing next-generation consumables tailored to emerging modalities, such as cell and gene therapies.

Actionable Roadmap for Testing Consumables Excellence

Leaders within the biopharmaceutical consumables testing sector should prioritize multi-tier supply chain diversification to guard against tariff-driven disruptions and regional shortages. Establishing strategic partnerships with regional producers of chromatography resins and depth filters will ensure critical inputs remain accessible, while maintaining a balanced inventory of single-use assemblies can mitigate lead-time variability during scale-up phases.

Investment in digital integration across testing workflows will yield substantial returns in both data integrity and operational efficiency. By implementing connected sampling assemblies and sensor-enabled bags, organizations can harness real-time analytics to detect deviations early, reduce batch rejects, and support continuous process verification. Training cross-functional teams in PAT principles and automated assay platforms will further accelerate quality-by-design initiatives.

Finally, embracing sustainable materials and reusability initiatives where feasible can enhance corporate responsibility credentials without compromising performance. Collaboration with technology developers to test novel membrane formulations or recyclable bioreactor liners can position organizations at the forefront of eco-efficient manufacturing, responding proactively to evolving regulatory and stakeholder expectations.

Rigorous Integration of Primary Insights and Data Triangulation

This research draws upon a blended methodology that integrates primary stakeholder interviews, technical literature reviews, and proprietary data triangulation. Thought leaders from biopharmaceutical manufacturers, contract organizations, and regulatory agencies provided firsthand perspectives on emerging challenges and priorities. Concurrently, detailed analyses of product catalogs, patent filings, and sustainability reports informed the evaluation of materials trends and innovation pipelines.

Quantitative and qualitative insights were cross-validated through a multi-stage review process. Data points on tariff impacts, technological adoption rates, and regional supply chain metrics were corroborated against publicly available trade statistics and internal benchmarking databases. The resulting narrative maps industry dynamics without relying on market sizing or forecasting projections, ensuring an objective, actionable foundation for strategic decision-making.

Synthesis of Testing Trends and Strategic Imperatives

The biopharmaceutical manufacturing consumables testing landscape is undergoing a period of rapid transformation driven by technological convergence, regulatory evolution, and shifting trade dynamics. As single-use technologies, advanced analytics, and sustainability imperatives reshape quality control frameworks, organizations must adapt supply chains and testing protocols to maintain product integrity and operational agility.

By understanding the nuanced segmentation of product types, testing modalities, technologies, applications, and end-user needs across key regions, industry leaders can identify targeted opportunities for innovation and partnership. The strategic moves of leading suppliers, coupled with actionable roadmaps for supply chain diversification and digital integration, provide a clear blueprint for achieving testing excellence and securing competitive advantage.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Chromatography Media
      • Affinity Resins
      • Ion Exchange Resins
      • Protein A Resins
      • Size Exclusion Media
    • Filtration Consumables
      • Cartridge Filters
      • Depth Filters
      • Membrane Filters
    • Sampling Assemblies
    • Single-Use Bags And Assemblies
      • Bioreactor Bags
      • Mixing Bags
      • Storage Bags
    • Tubing And Connectors
  • Testing Type
    • Bioburden Testing
    • Endotoxin Testing
    • pH Testing
    • Sterility Testing
      • Direct Inoculation Test
      • Membrane Filtration Test
  • Technology
    • ELISA
      • Competitive ELISA
      • Indirect ELISA
      • Sandwich ELISA
    • Flow Cytometry
    • Mass Spectrometry
    • Real-Time PCR
  • Application
    • Cell Culture Monitoring
    • Protein Purification
      • Affinity Chromatography
      • Ion Exchange Chromatography
      • Size Exclusion Chromatography
    • Viral Clearance
  • End User
    • Academic And Research Institutes
    • Biopharmaceutical Companies
      • Biosimilar Manufacturers
      • Large Pharma
      • Mid-Size Pharma
    • Contract Manufacturing Organizations
    • Contract Research Organizations
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Sartorius AG
  • Corning Incorporated
  • Agilent Technologies Inc.
  • Lonza Group AG
  • PerkinElmer Inc.
  • Tecan Group Ltd
  • Repligen Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biopharmaceuticals Manufacturing Consumables Testing Market, by Product Type
8.1. Introduction
8.2. Chromatography Media
8.2.1. Affinity Resins
8.2.2. Ion Exchange Resins
8.2.3. Protein A Resins
8.2.4. Size Exclusion Media
8.3. Filtration Consumables
8.3.1. Cartridge Filters
8.3.2. Depth Filters
8.3.3. Membrane Filters
8.4. Sampling Assemblies
8.5. Single-Use Bags And Assemblies
8.5.1. Bioreactor Bags
8.5.2. Mixing Bags
8.5.3. Storage Bags
8.6. Tubing And Connectors
9. Biopharmaceuticals Manufacturing Consumables Testing Market, by Testing Type
9.1. Introduction
9.2. Bioburden Testing
9.3. Endotoxin Testing
9.4. pH Testing
9.5. Sterility Testing
9.5.1. Direct Inoculation Test
9.5.2. Membrane Filtration Test
10. Biopharmaceuticals Manufacturing Consumables Testing Market, by Technology
10.1. Introduction
10.2. ELISA
10.2.1. Competitive ELISA
10.2.2. Indirect ELISA
10.2.3. Sandwich ELISA
10.3. Flow Cytometry
10.4. Mass Spectrometry
10.5. Real-Time PCR
11. Biopharmaceuticals Manufacturing Consumables Testing Market, by Application
11.1. Introduction
11.2. Cell Culture Monitoring
11.3. Protein Purification
11.3.1. Affinity Chromatography
11.3.2. Ion Exchange Chromatography
11.3.3. Size Exclusion Chromatography
11.4. Viral Clearance
12. Biopharmaceuticals Manufacturing Consumables Testing Market, by End User
12.1. Introduction
12.2. Academic And Research Institutes
12.3. Biopharmaceutical Companies
12.3.1. Biosimilar Manufacturers
12.3.2. Large Pharma
12.3.3. Mid-Size Pharma
12.4. Contract Manufacturing Organizations
12.5. Contract Research Organizations
13. Americas Biopharmaceuticals Manufacturing Consumables Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Biopharmaceuticals Manufacturing Consumables Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Biopharmaceuticals Manufacturing Consumables Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Danaher Corporation
16.3.3. Merck KGaA
16.3.4. Sartorius AG
16.3.5. Corning Incorporated
16.3.6. Agilent Technologies Inc.
16.3.7. Lonza Group AG
16.3.8. PerkinElmer Inc.
16.3.9. Tecan Group Ltd
16.3.10. Repligen Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET MULTI-CURRENCY
FIGURE 2. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET MULTI-LANGUAGE
FIGURE 3. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY AFFINITY RESINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ION EXCHANGE RESINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN A RESINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SIZE EXCLUSION MEDIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CARTRIDGE FILTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY DEPTH FILTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY MEMBRANE FILTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SAMPLING ASSEMBLIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOREACTOR BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY MIXING BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STORAGE BAGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TUBING AND CONNECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOBURDEN TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ENDOTOXIN TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PH TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY DIRECT INOCULATION TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY MEMBRANE FILTRATION TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COMPETITIVE ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY INDIRECT ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SANDWICH ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CELL CULTURE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ION EXCHANGE CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SIZE EXCLUSION CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY VIRAL CLEARANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOSIMILAR MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY MID-SIZE PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 85. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, 2018-2030 (USD MILLION)
TABLE 87. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 88. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, 2018-2030 (USD MILLION)
TABLE 89. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 90. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, 2018-2030 (USD MILLION)
TABLE 91. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 93. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 95. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. CANADA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, 2018-2030 (USD MILLION)
TABLE 99. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 100. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, 2018-2030 (USD MILLION)
TABLE 101. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 102. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, 2018-2030 (USD MILLION)
TABLE 103. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 105. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 107. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. MEXICO BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 156. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 158. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, 2018-2030 (USD MILLION)
TABLE 160. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 161. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, 2018-2030 (USD MILLION)
TABLE 162. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 163. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, 2018-2030 (USD MILLION)
TABLE 164. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 166. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 168. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. GERMANY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 170. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, 2018-2030 (USD MILLION)
TABLE 172. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 173. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, 2018-2030 (USD MILLION)
TABLE 174. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 175. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, 2018-2030 (USD MILLION)
TABLE 176. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 178. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 180. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. FRANCE BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 194. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, 2018-2030 (USD MILLION)
TABLE 196. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 197. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, 2018-2030 (USD MILLION)
TABLE 198. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 199. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, 2018-2030 (USD MILLION)
TABLE 200. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 202. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 203. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 204. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. ITALY BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 206. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, 2018-2030 (USD MILLION)
TABLE 208. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 209. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, 2018-2030 (USD MILLION)
TABLE 210. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 211. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, 2018-2030 (USD MILLION)
TABLE 212. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 214. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 216. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. SPAIN BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY STERILITY TESTING, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PROTEIN PURIFICATION, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY CHROMATOGRAPHY MEDIA, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY FILTRATION CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA BIOPHARMACEUTICALS MANUFACTURING CONSUMABLES TESTING MARKET SIZE, BY SINGLE-USE BAGS AND ASSEMBLIES, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA BIO

Companies Mentioned

The companies profiled in this Biopharmaceuticals Manufacturing Consumables Testing market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Sartorius AG
  • Corning Incorporated
  • Agilent Technologies Inc.
  • Lonza Group AG
  • PerkinElmer Inc.
  • Tecan Group Ltd
  • Repligen Corporation

Methodology

Loading
LOADING...

Table Information